Infectious Disease Pharmacotherapy Essentials
Essential antibiotics, antifungals, and antivirals with resistance patterns, empiric therapy selection, and dosing adjustments for NAPLEX success.
Master infectious disease pharmacotherapy with free flashcards and evidence-based clinical decision-making practice. This lesson covers antibiotic selection by pathogen, resistance mechanisms, empiric therapy protocols, and renal dosing adjustmentsβessential skills for the NAPLEX and clinical pharmacy practice. π¦
Welcome to Infectious Disease Pharmacotherapy
Infectious disease pharmacotherapy represents one of the most dynamic areas tested on the NAPLEX. Unlike cardiovascular medications where therapy is often chronic and predictable, antimicrobial selection requires rapid clinical decision-making based on infection site, likely pathogens, local resistance patterns, and patient-specific factors. The NAPLEX emphasizes application over memorizationβyou'll need to select appropriate empiric therapy, adjust for renal function, recognize drug interactions, and counsel patients on adherence and adverse effects.
This lesson builds on basic pharmacology by focusing on clinical scenarios you'll encounter in practice and on the exam. We'll explore the top antimicrobials by class, their spectra of activity, and most importantly, when NOT to use them. π
Core Concepts in Antimicrobial Therapy
The Empiric Therapy Framework π―
Empiric therapy means starting treatment before culture results return (usually 48-72 hours). Your selection depends on:
π The 5 Questions for Every Infection
| 1. Where is the infection? | Site determines likely pathogens (UTI vs pneumonia vs skin) |
| 2. Community or hospital-acquired? | Affects resistance likelihood (MRSA, Pseudomonas) |
| 3. What are patient risk factors? | Immunocompromised, recent antibiotics, allergies |
| 4. What's the renal/hepatic function? | Determines dosing adjustments needed |
| 5. What are local resistance patterns? | Antibiogram guides empiric choices |
Antibiotic Classes by Mechanism π¬
Cell Wall Synthesis Inhibitors (bactericidal)
- Beta-lactams: Penicillins, cephalosporins, carbapenems, monobactams
- Vancomycin: Glycopeptide for Gram-positive including MRSA
- Key concept: Time-dependent killing (maximize time above MIC)
Protein Synthesis Inhibitors (mostly bacteriostatic)
- Tetracyclines (doxycycline): Broad spectrum, avoid in pregnancy
- Macrolides (azithromycin): Atypical coverage, QT prolongation risk
- Aminoglycosides (gentamicin): Gram-negative, concentration-dependent killing
- Linezolid: MRSA alternative, watch for serotonin syndrome
DNA/RNA Synthesis Inhibitors
- Fluoroquinolones (levofloxacin, ciprofloxacin): Broad spectrum, tendon rupture/QT risk
- Metronidazole: Anaerobes and C. difficile
Folate Synthesis Inhibitors
- Trimethoprim-sulfamethoxazole (TMP-SMX): UTIs, MRSA, PCP prophylaxis
Understanding Antimicrobial Spectrum π
SPECTRUM OF ACTIVITY: Common Antibiotics
Gram + Gram - Atypical Anaerobes
------- ------- -------- ---------
Penicillin G ββββ ββββ ββββ ββββ
Amoxicillin ββββ ββββ ββββ ββββ
Amox-Clav ββββ ββββ ββββ ββββ
Cefazolin (1st gen) ββββ ββββ ββββ ββββ
Ceftriaxone (3rd) ββββ ββββ ββββ ββββ
Cefepime (4th) ββββ ββββ ββββ ββββ
Azithromycin ββββ ββββ ββββ ββββ
Levofloxacin ββββ ββββ ββββ ββββ
Vancomycin ββββ ββββ ββββ ββββ
Metronidazole ββββ ββββ ββββ ββββ
ββββ = Excellent ββββ = Limited ββββ = None
π‘ NAPLEX Tip: The exam loves testing spectrum gaps. Know that vancomycin has ZERO Gram-negative activity and that standard penicillin won't cover MRSA.
Beta-Lactam Allergy: The 10% Rule β οΈ
Approximately 10% of patients report penicillin allergy, but only 1-2% have true IgE-mediated reactions. The NAPLEX will test your ability to distinguish:
| Reaction Type | Symptoms | Can Use Other Beta-Lactams? |
|---|---|---|
| Type I (IgE) | Anaphylaxis, angioedema, bronchospasm within 1 hour | β Avoid all beta-lactams (10% cross-reactivity) |
| Delayed | Maculopapular rash after days | β May use cephalosporins (different side chain) |
| Non-allergic | GI upset, "didn't agree with me" | β Can use any beta-lactam |
π§ Mnemonic for Anaphylaxis Alternatives: "VALF" - Vancomycin, Aztreonam, Levofloxacin, Fluoroquinolones
Community-Acquired Pneumonia (CAP) Protocol π«
CAP is a NAPLEX favorite because it integrates pathogen knowledge, guideline adherence, and severity assessment.
Outpatient CAP (otherwise healthy)
- First-line: Amoxicillin 1g TID Γ 5-7 days
- Alternative: Doxycycline 100mg BID or azithromycin 500mg Γ 5 days
- With comorbidities: Amoxicillin-clavulanate + macrolide OR respiratory fluoroquinolone (levofloxacin 750mg daily)
Inpatient CAP (non-ICU)
- Beta-lactam (ceftriaxone 1-2g daily) + macrolide (azithromycin 500mg daily)
- OR respiratory fluoroquinolone monotherapy (levofloxacin 750mg daily)
Severe CAP (ICU)
- Beta-lactam + macrolide OR beta-lactam + fluoroquinolone
- Add vancomycin or linezolid if MRSA risk factors present
CAP PATHOGEN DECISION TREE
Community-Acquired Pneumonia
|
βββββββββββ΄βββββββββββ
β β
Outpatient Inpatient
| |
ββββββ΄βββββ βββββββ΄βββββββ
β β β β
Healthy Comorbid Non-ICU ICU
| | | |
β β β β
Amox Amox-Clav CTX+Azith CTX+Azith
or + or +
Doxyc Macrolide Levoflox Vanc (if MRSA)
π‘ Why add a macrolide? Covers atypical pathogens (Mycoplasma, Chlamydophila, Legionella) that beta-lactams miss.
Urinary Tract Infections: Uncomplicated vs. Complicated π½
Uncomplicated Cystitis (healthy women)
- First-line: Nitrofurantoin 100mg BID Γ 5 days OR TMP-SMX DS BID Γ 3 days
- Alternatives: Fosfomycin 3g Γ 1 dose
- β οΈ Avoid fluoroquinolones (FDA black box warnings, save for complicated infections)
Complicated UTI or Pyelonephritis
- Outpatient: Ciprofloxacin 500mg BID Γ 7 days OR levofloxacin 750mg daily Γ 5 days
- Inpatient: Ceftriaxone 1g daily (step down to oral based on culture)
Asymptomatic Bacteriuria
- Do NOT treat except in pregnancy or before urologic procedures
- NAPLEX loves testing thisβunnecessary antibiotics promote resistance!
| Drug | Advantages | Disadvantages | Key Point |
|---|---|---|---|
| Nitrofurantoin | Low resistance, preserves gut flora | CrCl <30: ineffective, pulmonary fibrosis with long-term use | Only for cystitis, not pyelonephritis |
| TMP-SMX | Inexpensive, effective | High resistance in some areas (>20%), hyperkalemia risk | Check local antibiogram |
| Fosfomycin | Single dose, excellent adherence | Lower efficacy than 5-day courses | Good for adherence concerns |
| Ciprofloxacin | Excellent Gram-negative coverage | FDA warnings: tendon rupture, neuropathy, aortic dissection | Reserve for complicated UTI |
Renal Dosing Adjustments: The Critical Skill π§
Many antimicrobials require dose adjustment for renal impairment. The NAPLEX will test calculations and clinical judgment.
Creatinine Clearance (CrCl) Calculation - Cockcroft-Gault
Male: CrCl = [(140 - age) Γ IBW] / (SCr Γ 72) Female: CrCl = [(140 - age) Γ IBW Γ 0.85] / (SCr Γ 72) Where: age = years IBW = Ideal Body Weight (kg) SCr = Serum Creatinine (mg/dL)
Common Renal Dosing Adjustments
| Drug | CrCl >50 | CrCl 30-50 | CrCl 10-30 | CrCl <10 |
|---|---|---|---|---|
| Levofloxacin | 750mg daily | 750mg Γ 1, then 500mg q48h | 750mg Γ 1, then 500mg q48h | 500mg Γ 1, then 250mg q48h |
| Ceftriaxone | No adjustment | No adjustment | No adjustment (hepatic excretion) | No adjustment |
| Vancomycin | 15-20mg/kg q12h | Increase interval or decrease dose | Dose by levels | Dose by levels |
| Acyclovir | 800mg 5Γ/day | 800mg TID | 800mg BID | 800mg daily |
π‘ NAPLEX Pearl: Ceftriaxone is unique among cephalosporinsβit's eliminated hepatically AND renally, so no dose adjustment needed even in severe renal impairment.
Skin and Soft Tissue Infections (SSTIs) π©Ή
SSTIs range from simple cellulitis to life-threatening necrotizing fasciitis. The key is distinguishing purulent vs. non-purulent.
Non-Purulent Cellulitis (no abscess)
- Likely pathogen: Streptococcus pyogenes (Group A Strep)
- Treatment: Cephalexin 500mg QID Γ 5-7 days OR dicloxacillin 500mg QID
- Penicillin allergy: Clindamycin 300-450mg TID
Purulent SSTI (abscess, furuncle)
- Likely pathogen: S. aureus including MRSA
- Treatment: Incision & drainage + TMP-SMX DS BID Γ 5-7 days OR doxycycline 100mg BID
- Alternative: Clindamycin 300-450mg TID (watch for inducible resistance)
Severe/Complicated SSTI
- IV vancomycin 15-20mg/kg q12h (target trough 15-20 mcg/mL)
- Alternative: Daptomycin 4-6mg/kg daily (NOT for pneumoniaβinactivated by surfactant)
- Linezolid 600mg BID (expensive, risk of myelosuppression and serotonin syndrome)
SSTI TREATMENT ALGORITHM
Skin Infection
|
ββββββββββ΄ββββββββββ
β β
Purulent Non-purulent
(abscess) (cellulitis)
| |
I&D + oral Oral beta-lactam
| |
ββββββ΄βββββ β
β β Cephalexin
Mild Severe or
| | Dicloxacillin
β β
TMP-SMX Vancomycin
or IV
Doxyc
β οΈ Common NAPLEX Trap: Don't use daptomycin for pneumonia! It binds to pulmonary surfactant and becomes inactive.
Clostridioides difficile Infection (CDI) π©
CDI results from antibiotic-induced disruption of gut flora. The 2021 IDSA guidelines changed first-line therapy.
Initial Episode (non-severe)
- First-line: Fidaxomicin 200mg BID Γ 10 days (expensive but lower recurrence)
- Alternative: Vancomycin 125mg PO QID Γ 10 days
- β οΈ Metronidazole NO LONGER first-line (inferior cure rates)
Initial Episode (severe) - WBC >15,000 OR SCr β₯1.5Γ baseline
- Vancomycin 125mg PO QID Γ 10 days
- Fulminant: Vancomycin 500mg PO QID + metronidazole 500mg IV q8h
First Recurrence
- Vancomycin taper/pulse regimen OR fidaxomicin 200mg BID Γ 10 days
Second Recurrence
- Fecal microbiota transplant (FMT) - 90% cure rate!
- Bezlotoxumab (monoclonal antibody) as adjunct to reduce recurrence
π§ Mnemonic for CDI Risk Factors: "CAFE" - Clindamycin/cephalosporins, Age >65, Fluoroquinolones, Exposure to healthcare
Antiviral Therapy: Focus on Common Infections π¦
Influenza
- Oseltamivir (Tamiflu) 75mg BID Γ 5 days
- Must start within 48 hours of symptom onset for benefit
- Reduces duration by ~1 day, prevents complications in high-risk patients
- Dose adjustment: CrCl 10-30: 30mg BID; CrCl <10: 30mg daily
Herpes Simplex (HSV)
- Genital HSV (first episode): Acyclovir 400mg TID Γ 7-10 days OR valacyclovir 1g BID Γ 7-10 days
- Genital HSV (recurrence): Valacyclovir 500mg BID Γ 3 days
- Suppressive therapy: Valacyclovir 500-1000mg daily (reduces transmission by 50%)
- Herpes labialis: Acyclovir cream 5Γ daily OR valacyclovir 2g BID Γ 1 day
Herpes Zoster (Shingles)
- Valacyclovir 1g TID Γ 7 days OR acyclovir 800mg 5Γ/day Γ 7 days
- Start within 72 hours of rash onset
- Consider higher doses in immunocompromised patients
π‘ Valacyclovir vs. Acyclovir: Valacyclovir is a prodrug with better bioavailability (54% vs. 10-20%), allowing less frequent dosing and better adherence.
Antifungal Therapy Essentials π
Oral Candidiasis (Thrush)
- First-line: Nystatin suspension 400,000-600,000 units (swish & swallow) QID Γ 7-14 days
- Fluconazole-refractory: Itraconazole solution 200mg daily OR posaconazole 400mg BID Γ 3 days, then 400mg daily
Vulvovaginal Candidiasis (VVC)
- Uncomplicated: Fluconazole 150mg PO Γ 1 dose OR topical azole (miconazole, clotrimazole) Γ 1-7 days
- Complicated/Recurrent: Fluconazole 150mg on days 1, 4, 7 then weekly Γ 6 months
Invasive Candidiasis
- Echinocandin preferred: Caspofungin 70mg load, then 50mg daily OR micafungin 100mg daily
- Alternative: Fluconazole 800mg load, then 400mg daily (if susceptible)
Drug Interactions with Azoles β οΈ
Azoles (fluconazole, itraconazole, voriconazole, posaconazole) are potent CYP3A4 inhibitors:
| Interacting Drug | Effect | Management |
|---|---|---|
| Warfarin | β INR, bleeding risk | Monitor INR closely, may need 20-30% warfarin dose reduction |
| Statins | β myopathy/rhabdomyolysis risk | Avoid simvastatin/lovastatin; use atorvastatin with dose limit |
| Tacrolimus | β levels, nephrotoxicity | Reduce tacrolimus dose by 50-70%, monitor levels |
| Benzodiazepines | β sedation | Avoid triazolam/midazolam; use lorazepam instead |
| Phenytoin | β phenytoin levels; β azole levels | Bidirectional interaction, monitor both |
Clinical Examples
Example 1: Pneumonia with Renal Impairment π«
Case: A 72-year-old man presents to the ED with productive cough, fever (38.9Β°C), and hypoxemia. Chest X-ray shows right lower lobe infiltrate. He has a history of hypertension and CKD stage 3 (baseline SCr 1.8 mg/dL). Weight 80 kg, no drug allergies.
Clinical Decision-Making Process:
| Step | Assessment | Decision |
|---|---|---|
| 1 | Severity assessment | Inpatient CAP (non-ICU) based on oxygen requirement |
| 2 | Empiric regimen selection | Beta-lactam + macrolide OR fluoroquinolone |
| 3 | Calculate CrCl | CrCl = [(140-72) Γ 80] / (1.8 Γ 72) = 42 mL/min |
| 4 | Renal adjustment needed? | Yes for levofloxacin (CrCl 30-50 range) |
| 5 | Final recommendation | Ceftriaxone 1g IV daily + azithromycin 500mg IV daily |
Rationale:
- Ceftriaxone: No renal adjustment needed (dual excretion)
- Azithromycin: No renal adjustment needed (hepatic excretion)
- Alternative would be levofloxacin 750mg Γ 1, then 500mg q48h (adjusted for CrCl 42)
- Duration: Minimum 5 days, until clinically stable (afebrile 48-72h, able to eat, normal mentation)
π‘ NAPLEX Application: The exam might present this case and ask: "Which regimen requires NO dose adjustment?" The answer would be ceftriaxone + azithromycin.
Example 2: MRSA SSTI with Drug Interaction π©Ή
Case: A 45-year-old woman presents with a large, fluctuant abscess on her thigh. I&D performed with purulent drainage. She takes sertraline 100mg daily for depression. Past cultures have grown MRSA. She requests oral therapy as she travels frequently for work.
Medication Options Analysis:
| Drug | Pros | Cons | Recommendation |
|---|---|---|---|
| TMP-SMX DS BID | Excellent MRSA coverage, BID dosing | None in this case | β Best choice |
| Doxycycline 100mg BID | Good coverage, BID dosing | Photosensitivity warning | β Acceptable alternative |
| Linezolid 600mg BID | Excellent MRSA coverage | β οΈ Risk of serotonin syndrome with sertraline! | β Avoid |
| Clindamycin 300mg TID | Good coverage if susceptible | Need D-test for inducible resistance | β οΈ Only if D-test negative |
Decision: Prescribe TMP-SMX DS 1 tab BID Γ 7 days
Critical counseling points:
- Take with full glass of water to prevent crystalluria
- Stay hydrated (2-3 liters daily)
- Watch for rash (Stevens-Johnson syndrome risk, though rare)
- Monitor for hyperkalemia if on ACE inhibitors or ARBs
- Finish entire course even if abscess improves quickly
β οΈ NAPLEX Focus: Linezolid + SSRI/SNRI = serotonin syndrome risk! This is a high-yield drug interaction. Symptoms include agitation, confusion, tremor, hyperthermia, and muscle rigidity.
Example 3: UTI in Pregnancy π€°
Case: A 28-year-old woman at 14 weeks gestation presents with dysuria, frequency, and urgency. Urinalysis shows WBC 50-100, nitrite positive, bacteria present. No fever or flank pain. Allergies: Sulfa drugs (hives as a child).
Pregnancy Considerations for UTI Therapy:
| Drug | Pregnancy Category/Safety | Use in This Case? |
|---|---|---|
| Nitrofurantoin | Avoid at term (risk of hemolytic anemia in newborn), OK in 2nd trimester | β Best option |
| TMP-SMX | Avoid 1st trimester (neural tube defects) & at term (kernicterus) | β Sulfa allergy + 2nd trimester concerns |
| Amoxicillin-clavulanate | Safe throughout pregnancy | β Good option |
| Cephalexin | Safe throughout pregnancy | β Good option |
| Fluoroquinolones | β Avoid - cartilage damage in fetus | β Contraindicated |
| Tetracyclines | β Avoid - teeth staining, bone effects | β Contraindicated |
Decision: Nitrofurantoin monohydrate 100mg BID Γ 5 days OR Cephalexin 500mg QID Γ 5 days
Additional management:
- Follow-up urine culture in 1-2 weeks to document cure
- Consider suppressive therapy (nitrofurantoin 50-100mg daily) for remainder of pregnancy if recurrent UTIs
- Asymptomatic bacteriuria MUST be treated in pregnancy (unlike non-pregnant patients) due to pyelonephritis risk
π‘ NAPLEX Pearl: Pregnancy is one of the few situations where you MUST treat asymptomatic bacteriuria. Untreated bacteriuria leads to pyelonephritis in 20-30% of pregnant women.
Example 4: Antibiotic Stewardship Decision π―
Case: A 35-year-old man presents to urgent care with 3 days of nasal congestion, facial pressure, and clear nasal discharge. No fever. He requests "a Z-pack" because "it always helps my sinus infections."
Stewardship Analysis:
VIRAL RHINOSINUSITIS vs BACTERIAL SINUSITIS
Symptoms < 10 days?
|
ββββββββ΄βββββββ
β β
YES NO
| |
Likely VIRAL Consider
| bacterial
β |
No antibiotics Still wait?
| |
β ββββββ΄βββββ
Supportive β β
care Mild Severe
| | |
β β β
- Saline Wait 7 Antibiotics
- Decongest more if no
- NSAIDs days improvement
Decision: No antibiotics indicated
Counseling: "Your symptoms suggest a viral sinus infection, which antibiotics won't help. Viral infections typically last 7-10 days. I recommend:
- Saline nasal irrigation 2-3 times daily (most effective!)
- Pseudoephedrine 30-60mg every 4-6 hours for congestion (check BP first)
- Ibuprofen 400mg every 6 hours as needed for pain
- Return if symptoms worsen after initial improvement, persist beyond 10 days, or you develop fever >38.3Β°C"
When to treat acute bacterial sinusitis:
- Severe symptoms (fever β₯39Β°C + purulent discharge β₯3 days)
- Worsening after initial improvement ("double sickening")
- Persistent symptoms β₯10 days without improvement
If antibiotics indicated: Amoxicillin-clavulanate 875/125mg BID Γ 5-7 days (covers S. pneumoniae including resistant strains and H. influenzae)
β οΈ NAPLEX Stewardship Question: The exam might show this case and ask which action is most appropriate. The answer is symptomatic treatment without antibiotics + counseling on when to return.
Common Mistakes to Avoid β οΈ
1. Using IV vancomycin for C. difficile infection β Wrong: IV vancomycin doesn't reach colonic lumen in therapeutic concentrations β Right: ORAL vancomycin or fidaxomicin (need drug in GI tract where C. diff lives)
2. Prescribing nitrofurantoin for pyelonephritis β Wrong: Nitrofurantoin doesn't achieve adequate tissue levels in kidney β Right: Use nitrofurantoin ONLY for cystitis (bladder infection); choose fluoroquinolone or ceftriaxone for pyelonephritis
3. Forgetting to adjust aminoglycoside dosing based on weight AND renal function β Wrong: Using standard dose without calculating based on actual body weight β Right: Gentamicin loading dose = 5-7mg/kg (use ABW for obese patients), then adjust interval based on CrCl and levels
4. Missing the QT prolongation risk with azithromycin + other QT-prolonging drugs β Wrong: Prescribing Z-pack to patient on amiodarone without considering interaction β Right: Choose alternative antibiotic (doxycycline) or monitor ECG if macrolide essential
5. Treating viral pharyngitis with antibiotics β Wrong: "Strep throat" = antibiotics for everyone with sore throat β Right: Use Centor criteria; only treat if β₯3 criteria OR positive rapid strep test
6. Using ceftriaxone in neonates receiving calcium-containing IV solutions β Wrong: Can cause fatal precipitation in lungs and kidneys β Right: Use alternative cephalosporin (cefotaxime) in neonates, especially if on IV calcium
7. Forgetting about double coverage for Pseudomonas in severe infections β Wrong: Single antipseudomonal agent for pneumonia in ICU patient with bronchiectasis β Right: Use two agents with different mechanisms (e.g., cefepime + tobramycin) until sensitivities known
8. Inadequate duration of therapy for endocarditis or osteomyelitis β Wrong: Treating with standard 7-10 day course β Right: Endocarditis = 4-6 weeks IV, osteomyelitis = minimum 4-6 weeks (often longer)
Key Takeaways π
π― NAPLEX Success Strategy for Infectious Disease
Master These Core Principles:
- Spectrum matters more than drug names - Know what each class covers (Gram+, Gram-, atypicals, anaerobes)
- Site of infection guides empiric therapy - Pneumonia β UTI β SSTI in pathogen likelihood
- Renal dosing is non-negotiable - Calculate CrCl, adjust accordingly
- Allergy assessment is critical - Distinguish true IgE reactions from intolerances
- Stewardship prevents resistance - Not every infection needs antibiotics
High-Yield Drug Interactions:
- Fluoroquinolones + divalent cations = β absorption (separate by 2-6 hours)
- Linezolid + SSRIs/SNRIs = serotonin syndrome
- Azoles + warfarin = β INR
- Rifampin + everything = β levels (potent CYP inducer)
Pregnancy Red Flags:
- β Safe: Penicillins, cephalosporins, azithromycin, nitrofurantoin (not at term)
- β Avoid: Fluoroquinolones, tetracyclines, TMP-SMX (1st trimester/term), aminoglycosides
Counseling Essentials:
- Complete the course (even if feeling better)
- Take with/without food as directed
- Warning signs to return (worsening symptoms, rash, severe diarrhea)
- Storage (refrigerate suspensions)
- Drug-specific warnings (photosensitivity, discolored urine, etc.)
NAPLEX Question Strategies:
- Application over recall: Expect cases requiring you to SELECT therapy, not just define drugs
- Calculate before answering: Many questions require CrCl calculation for dosing
- Read carefully for contraindications: Allergy history, pregnancy status, organ dysfunction
- Consider the whole patient: Concurrent medications, comorbidities, adherence factors
π Further Study
Evidence-Based Guidelines:
- IDSA Clinical Practice Guidelines: https://www.idsociety.org/practice-guideline/practice-guidelines/
- CDC Antibiotic Prescribing and Use: https://www.cdc.gov/antibiotic-use/
- Sanford Guide to Antimicrobial Therapy (subscription): https://www.sanfordguide.com/
Practice Resources:
- NAPLEX Competency Statements (focus on Area 1): https://nabp.pharmacy/programs/naplex/
- Johns Hopkins Antibiotic Guide: https://www.hopkinsguides.com/hopkins/index/Johns_Hopkins_ABX_Guide
Master infectious disease pharmacotherapy by practicing case-based questions, calculating renal doses until it becomes automatic, and understanding the "why" behind empiric therapy choices. The NAPLEX rewards clinical reasoningβthink like a pharmacist, not just a student! ππ